Group One Trading
NRXP icon

Group One Trading’s NRX Pharmaceuticals NRXP Stock Holding History

Group One Trading’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-737
Closed -$2.43K – 8198
2026
Q1 		$1.57K Buy
+737
New +$1.49K ﹤0.01% 7116
2025
Q3 		– Sell
-3,108
Closed -$8.9K – 8898
2025
Q2 		$10.1K Buy
+3,108
New +$7.79K ﹤0.01% 6711
2025
Q1 		– Sell
-99
Closed -$279 – 8112
2024
Q4 		$218 Buy
+99
New +$133 ﹤0.01% 7058
2024
Q2 		– Sell
-91
Closed -$428 – 7231
2024
Q1 		$428 Sell
91
-1,825
-95% -$8.41K ﹤0.01% 6756
2023
Q4 		$8.81K Hold
1,916
– – ﹤0.01% 6273
2023
Q3 		$4.98K Sell
1,916
-570
-23% -$1.9K ﹤0.01% 6710
2023
Q2 		$12K Buy
2,486
+353
+17% +$2.12K ﹤0.01% 6293
2023
Q1 		$14.1K Sell
2,133
-2,517
-54% -$25.5K ﹤0.01% 5751
2022
Q4 		$51.6K Sell
4,650
-6,708
-59% -$67.6K ﹤0.01% 4970
2022
Q3 		$84K Sell
11,358
-5,934
-34% -$40K ﹤0.01% 4929
2022
Q2 		$104K Buy
17,292
+13,903
+410% +$183K ﹤0.01% 4955
2022
Q1 		$83K Buy
3,389
+2,763
+441% +$89.9K ﹤0.01% 5675
2021
Q4 		$30K Sell
626
-131
-17% -$9.45K ﹤0.01% 6727
2021
Q3 		$70K Buy
+757
New +$98.5K ﹤0.01% 6260

Other funds holding NRXP

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading's NRXP Position: Q2 2026 in Review

Group One Trading sold out of NRX Pharmaceuticals (NRXP) in Q2 2026, closing a stake of 737 shares — an estimated $2.43K sold.

Group One Trading first reported a position in NRXP in Q3 2021 and held it in 14 quarters. The position peaked at $104K in Q2 2022. 46 funds tracked by Wall St. Rank hold NRXP as of Q2 2026.

  • Group One Trading reported no remaining NRX Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 737 NRX Pharmaceuticals shares in Q2 2026, an estimated $2.43K.
  • Group One Trading first reported a position in NRX Pharmaceuticals in Q3 2021 and held it in 14 quarters.
  • Group One Trading's NRX Pharmaceuticals position peaked at $104K in Q2 2022.
  • 46 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.